Home > Insider Trading > Filing (0001140361-12-021579)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
897448	Amarin Corp Plc	AMRN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1397144	Llp Abingworth	Princes House 38 Jermyn Street London X0 SW1Y 6DN		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares, 50 Pence Par Value Per Share	Disposition	2012-04-17	1,712,000	$9.61	3,895,509	No	4	S	Indirect	See Notes
Ordinary Shares, 50 Pence Par Value Per Share	Disposition	2012-04-18	1,614,341	$9.60	2,281,168	No	4	S	Indirect	See Notes
Ordinary Shares, 50 Pence Par Value Per Share	Disposition	2012-04-19	682,000	$9.66	1,599,168	No	4	S	Indirect	See Notes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Notes
No	4	S	Indirect	See Notes
No	4	S	Indirect	See Notes

Footnotes

Abingworth LLP (the "Reporting Person") is the investment manager to a number of investment funds that include Abingworth Bioventures V L.P. ("ABV V"), Abingworth Bioventures V Co-Invest Growth Equity Fund LP ("AGE"), and Abingworth Bioequities Master Fund Limited ("ABE," and collectively with ABV V and AGE, the "Abingworth Funds"). On April 17, 2012, ABV V sold 760,128 ordinary shares, 50 pence par value per share, of Amarin Corporation plc ("Ordinary Shares"), AGE sold 760,128 Ordinary Shares, and ABE sold 191,744 Ordinary Shares. On April 18, 2012, ABV V sold 716,767 Ordinary Shares, AGE sold 716,767 Ordinary Shares, and ABE sold 180,807 Ordinary Shares. On April 19, 2012, ABV V sold 302,808 Ordinary Shares, AGE sold 302,808 Ordinary Shares, and ABE sold 76,384 Ordinary Shares.
The Reporting Person may be deemed to beneficially own the Ordinary Shares reported herein indirectly through the Abingworth Funds. The Reporting Person's interest in the securities reported herein is limited to the extent of its pecuniary interest, if any, in the Abingworth Funds. This report shall not be deemed an admission that the Reporting Person, each Abingworth Fund or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.